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ABSTRACT 
Background: The consequence of Rho GDP dissociation inhibitor alpha (RhoGDIα) activity 
on migration and invasion of estrogen receptor positive (ER+) and negative (ER-) breast 
cancer cells has not been studied using the proteomic approach. Changes in expression of 
RhoGDIα and other proteins interacting directly or indirectly with RhoGDIα in MCF7 and 
MDA-MB-231, with different metastatic potentials is of particular interest. Materials and 
Methods: ER+ MCF7 and ER- MDA-MB-231 cell lines were subjected to two-dimensional 
electrophoresis (2-DE) and spots of interest were identified by matrix-assisted laser 
desorption/ionization time of- flight/timeof- flight (MALDI-TOF/TOF) mass spectrometry 
(MS) analysis after downregulation of RhoGDIα using short interfering RNA (siRNA) and 
upregulated using GFP-tagged ORF clone of RhoGDIα. Results: The results showed a total 
of 35 proteins that were either up- or down-regulated in these cells. Here we identifed 9 and 
15 proteins differentially expressed with silencing of RhoGDIα in MCF-7 and the MDA-MB-
231 cells, respectively. In addition, 10 proteins were differentially expressed in the 
upregulation of RhoGDIα in MCF7, while only one protein was identified in the upregulation 
of RhoGDIα in MDA-MB-231. Based on the biological functions of these proteins, the 
results revealed that proteins involved in cell migration are more strongly altered with 
RhoGDI-α activity. Although several of these proteins have been previously indicated in 
tumorigenesis and invasiveness of breast cancer cells, some ohave not been previously 
reported to be involved in breast cancer migration. Hence, these proteins may serve as useful 
candidate biomarkers for tumorigenesis and invasiveness of breast cancer cells. Conclusions: 
Future studies are needed to determine the mechanisms by which these proteins regulate cell 
migration. The combination of RhoGDIα with other potential biomarkers may be a more 
promising approach in the inhibition of breast cancer cell migration. 
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